Collectively, these results emphasize the relevance of IL-8, IL-17A, and IL-33 in the mechanisms of tumor invasion and support their potential utility as biomarkers and therapeutic targets in colorectal cancer management. This evidence concerns the gene IL33 and colorectal cancer.